Literature DB >> 2659277

Oral immunization with influenza virus: experimental and clinical studies.

K C Bergmann, R H Waldman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659277     DOI: 10.1007/978-3-642-74529-4_9

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  11 in total

1.  Cellular changes in the bronchoalveolar lavage (BAL) of pigs, following immunization by the enteral or respiratory route.

Authors:  S Delventhal; A Hensel; K Petzoldt; R Pabst
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

Review 2.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

3.  Lymphocyte subsets in bronchoalveolar lavage after exposure to Actinobacillus pleuropneumoniae in pigs previously immunized orally or by aerosol.

Authors:  R Pabst; S Delventhal; A Gebert; A Hensel; K Petzoldt
Journal:  Lung       Date:  1995       Impact factor: 2.584

Review 4.  Vaccination strategies for mucosal immune responses.

Authors:  P L Ogra; H Faden; R C Welliver
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 5.  Microneedle and mucosal delivery of influenza vaccines.

Authors:  Sang-Moo Kang; Jae-Min Song; Yeu-Chun Kim
Journal:  Expert Rev Vaccines       Date:  2012-05       Impact factor: 5.217

6.  Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.

Authors:  A C Menge; S M Michalek; M W Russell; J Mestecky
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 7.  Molecular heterogeneity of human IgA antibodies during an immune response.

Authors:  M W Russell; C Lue; A W van den Wall Bake; Z Moldoveanu; J Mestecky
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

8.  Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs.

Authors:  A Hensel; R Pabst; S Bunka; K Petzoldt
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

9.  Augmentation of anti-influenza virus hemagglutinin antibody production by Peyer's patch cells with Bifidobacterium breve YIT4064.

Authors:  H Yasui; N Nagaoka; K Hayakawa
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

Review 10.  Mucosal immunity and tolerance: relevance to vaccine development.

Authors:  C Czerkinsky; F Anjuere; J R McGhee; A George-Chandy; J Holmgren; M P Kieny; K Fujiyashi; J F Mestecky; V Pierrefite-Carle; C Rask; J B Sun
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.